US FDA clears cardiovascular surgery planning software

The US FDA has cleared a cardiovascular surgery planning software suite from Materialise (Leuven, Belgium) designed to provide support for transcatheter mitral valve replacements. Materialise (Leuven, Belgium) has announced its receipt of US FDA clearance for cardiovascular surgery planning software suite, 'Mimics Enlight Mitral'. The first release of this introductory workflow will reportedly support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures. Based on Mimics Innovation Suite software, Mimics Enlight is intended to support patient selection and planning for structural heart and vascular therapy with an 'easy-to-use clinical workflow' for planning complex procedures to correct mitral regurgitation - a...